This company has been marked as potentially delisted and may not be actively trading. Baudax Bio (BXRX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BXRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Baudax Bio Announces Corporate UpdateOctober 18, 2023 | finance.yahoo.comBaudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug TagOctober 2, 2023 | msn.comWhy Is Baudax Bio (BXRX) Stock Up 75% Today?September 28, 2023 | investorplace.comBaudax Bio Shares Double After Orphan Drug Designation for TI-168September 28, 2023 | marketwatch.comBaudax Bio: FDA Grants Orphan Drug Designation To TI-168 For Hemophilia A With InhibitorsSeptember 28, 2023 | markets.businessinsider.comHere's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock NowSeptember 18, 2023 | finance.yahoo.comBaudax Bio to Participate in the H.C. Wainwright Global Investment ConferenceSeptember 7, 2023 | finance.yahoo.comBaudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common StockAugust 23, 2023 | finance.yahoo.comBaudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 17, 2023 | finance.yahoo.comBaudax Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 16, 2023 | finance.yahoo.comWhy Is Baudax Bio (BXRX) Stock Up 130% Today?June 30, 2023 | investorplace.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 11:06 AM with a stated reason of "LULD pause."...June 30, 2023 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."...June 30, 2023 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."...June 30, 2023 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."...June 30, 2023 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."...June 30, 2023 | marketbeat.comBaudax Bio (BXRX) Gets a Hold from Noble FinancialJune 8, 2023 | markets.businessinsider.comNoble Financial Sticks to Their Hold Rating for Baudax Bio (BXRX)May 22, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Cocrystal Pharma (COCP) and Baudax Bio (BXRX)May 15, 2023 | markets.businessinsider.comBaudax Bio, Inc.: Baudax Bio Reports First Quarter Financial Results and Provides Business UpdateMay 12, 2023 | finanznachrichten.deBaudax Improves on Q1 ResultsMay 12, 2023 | baystreet.caRecap: Baudax Bio Q1 EarningsMay 12, 2023 | msn.comBaudax Bio Reports First Quarter Financial Results and Provides Business UpdateMay 12, 2023 | finance.yahoo.comBaudax Bio to Present at the Sidoti Virtual Investor ConferenceMay 3, 2023 | finance.yahoo.comBaudax Bio Announces Closing of $4 Million Public OfferingMay 1, 2023 | finance.yahoo.comWhy NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionApril 27, 2023 | msn.comWhy Is Baudax Bio (BXRX) Stock Down 52% Today?April 27, 2023 | investorplace.comBaudax Bio Announces Pricing of $4 Million Public OfferingApril 26, 2023 | finance.yahoo.comBaudax Bio Soars after Positive Topline DataApril 25, 2023 | msn.comBaudax Bio's Nerve Blockade Aces Mid-Stage Study In Surgery PatientsApril 25, 2023 | msn.comBaudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 TrialApril 24, 2023 | finance.yahoo.comLooking Into Baudax Bio's Return On Capital EmployedFebruary 28, 2023 | msn.comBaudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business UpdateFebruary 23, 2023 | finance.yahoo.comBaudax Bio Shares Drop 17% After Tuesday Rise on BX-1000 Trial ResultsJanuary 25, 2023 | marketwatch.comIs the Pain Over for Baudax Bio Investors after a 70% Spike? Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.January 25, 2023 | marketbeat.comWhy Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 24, 2023 | benzinga.comWhy Is Baudax Bio (BXRX) Stock Up 50% Today?January 24, 2023 | investorplace.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 09:01 AM with a stated reason of "LULD pause." Trading set to resume at 09:01 AM. January 24, 2023 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 09:01 AM with a stated reason of "LULD pause."...January 24, 2023 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 01:01 PM with a stated reason of "LULD pause."...January 3, 2023 | marketbeat.comWhy Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving PremarketDecember 9, 2022 | msn.comLab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapyDecember 9, 2022 | bizjournals.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 09:12 AM with a stated reason of "LULD pause."...December 9, 2022 | marketbeat.comBaudax Bio (Nasdaq:BXRX) HeadlineTrading was temporarily halted for "BXRX" at 09:12 AM with a stated reason of "LULD pause."...December 9, 2022 | marketbeat.comBaudax Bio, Inc.: Baudax Bio Announces 1-for-40 Reverse Stock SplitDecember 1, 2022 | finanznachrichten.deBaudax Bio Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 8, 2022 | finance.yahoo.comBaudax Bio Announces Distribution of Series B Preferred Stock to Holders of its Common StockSeptember 19, 2022 | finance.yahoo.comThinking about buying stock in Cisco Systems, Sonnet BioTherapeutics, Nikola Corp, Baudax Bio, or Amyris?September 14, 2022 | benzinga.comBaudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare ConferenceSeptember 8, 2022 | finance.yahoo.comBaudax Bio stock price plummets after firm announces $6.2M public offeringAugust 30, 2022 | bizjournals.com Get Baudax Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BXRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BXRX Media Mentions By Week BXRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BXRX News Sentiment▼0.000.93▲Average Medical News Sentiment BXRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BXRX Articles This Week▼00▲BXRX Articles Average Week Get the Latest News and Ratings for BXRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Baudax Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ATXI News CANF News UPC News VCNX News EVFM News PTPI News HEPA News BPTH News TRVN News VINC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BXRX) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baudax Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BXRX Stock Alerts